Category: Healthcare Finance News

Credit stress continues to rise in healthcare sector as maturities loom, social risks rise

Healthcare companies on Moody’s list of lower-rated companies have about $41.6 billion of outstanding debt, a 28% increase in the past year.

Interoperability rules risk patient privacy, say insurers, hospitals

Health information will be transferred outside the protections of federal privacy laws, with information bought and sold on the open market, AHIP says.

New report shows patient priorities in caregiver reviews

The MGAM and Healthgrades report also shows gender bias, with male doctors receiving higher average reviews than female providers.

Healthcare private equity had a record year with deal values close to $79 billion

The increasing size of healthcare deal values stemmed primarily from large buyouts, as the average deal size rose roughly 25%.

HHS finalizes rules requiring EHR access and ending information blocking

Health plans in Medicare Advantage, Medicaid, CHIP, and through the federal exchanges, must share claims data electronically with patients.

Dartmouth-Hitchcock Health says COVID-19 coronavirus is contained in New Hampshire

The health system said it has followed all of the proper procedures, and no new cases of the coronavirus have been detected so far in the state.

Despite red tape, most pediatricians are supportive of national vaccination program

The program has increased vaccination rates, decreased vaccine-preventable illnesses and reduced social and racial disparities.

Insurers will cover testing of coronavirus, AHIP says

Cigna and Aetna said they are waiving consumer co-pays, cost sharing and other out-of-pocket costs.

Coronavirus forces cancellation of HIMSS20

After monitoring the situation for weeks, CEO Hal Wolf says the 2020 HIMSS Global Health Conference & Exhibition will not proceed as hoped, given the health risks posed to attendees.

Coronavirus risk factors prompt public health concerns, though it’s not as deadly as SARS

If there’s one silver lining, it’s that while the coronavirus has had a significant global impact, it’s not as deadly as SARS or MERS.